OConnell Daniel Joseph

Track

Insider profile

OConnell Daniel Joseph's trades of Acumen Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
255.36
Quantity 4,575
Value US$789,276
Transaction date
Proposed sale
Price
1.81
Quantity 9,346
Value US$16,927
Transaction date
Proposed sale
Price
1.73
Quantity 5,388
Value US$9,307
Transaction date
Proposed sale
Price
1.76
Quantity 12,941
Value US$22,832
Transaction date
Proposed sale
Price
1.82
Quantity 8,143
Value US$14,815
Transaction date
Proposed sale
Price
1.99
Quantity 37,755
Value US$74,981
Transaction date
Proposed sale
Price
1.97
Quantity 5,102
Value US$10,031
Transaction date
Proposed sale
Price
1.97
Quantity 4,649
Value US$9,163
Transaction date
Proposed sale
Price
1.59
Quantity 12,619
Value US$20,109
Transaction date
Proposed sale
Price
1.84
Quantity 47,778
Value US$87,873
Transaction date
Proposed sale
Price
3.47
Quantity 15,200
Value US$52,753
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-23 2026-01-22
PlS Planned sale
93,283 -33.6%
123.02
US$4,223,909 		93,283 -33.6% 123.02 US$4,223,909
2026-01-22 2026-01-22
PrS Proposed sale
4,575
255.36
US$789,276 		4,575 255.36 US$789,276
2026-01-23 2026-01-21
PlS Planned sale
5,263 +26.8%
294.31
US$2,903,810 		5,263 +26.8% 294.31 US$2,903,810
2026-01-21 2026-01-21
PrS Proposed sale
9,346
1.81
US$16,927 		9,346 1.81 US$16,927
2026-01-12 2026-01-12
PrS Proposed sale
5,388
1.73
US$9,307 		5,388 1.73 US$9,307
2026-01-12 2026-01-12
PlS Planned sale
5,388 -0.9%
1.73
US$9,307 		5,388 -0.9% 1.73 US$9,307
2026-01-12 2026-01-09
PlS Planned sale
12,941 -2.1%
1.76
US$22,832 		12,941 -2.1% 1.76 US$22,832
2026-01-09 2026-01-09
PrS Proposed sale
12,941
1.76
US$22,832 		12,941 1.76 US$22,832
2026-01-12 2026-01-08
PlS Planned sale
8,143 -1.3%
1.82
US$14,815 		8,143 -1.3% 1.82 US$14,815
2026-01-08 2026-01-08
PrS Proposed sale
8,143
1.82
US$14,815 		8,143 1.82 US$14,815
2026-01-07 2026-01-07
PrS Proposed sale
37,755
1.99
US$74,981 		37,755 1.99 US$74,981
2026-01-07 2026-01-07
PlS Planned sale
37,755 -5.7%
1.99
US$74,981 		37,755 -5.7% 1.99 US$74,981
2026-01-07 2026-01-06
PlS Planned sale
5,102 -0.8%
1.97
US$10,032 		5,102 -0.8% 1.97 US$10,032
2026-01-06 2026-01-06
PrS Proposed sale
5,102
1.97
US$10,031 		5,102 1.97 US$10,031
2026-01-07 2026-01-05
PlS Planned sale
4,649 -0.7%
1.97
US$9,163 		4,649 -0.7% 1.97 US$9,163
2026-01-05 2026-01-05
PrS Proposed sale
4,649
1.97
US$9,163 		4,649 1.97 US$9,163
2025-01-23 2025-01-21
PlS Planned sale
12,619 -1.9%
1.59
US$20,102 		12,619 -1.9% 1.59 US$20,102
2025-01-21 2025-01-21
PrS Proposed sale
12,619
1.59
US$20,109 		12,619 1.59 US$20,109
2025-01-07 2025-01-03
PlS Planned sale
47,778 -9.5%
1.84
US$87,873 		47,778 -9.5% 1.84 US$87,873
2025-01-03 2025-01-03
PrS Proposed sale
47,778
1.84
US$87,873 		47,778 1.84 US$87,873
2024-01-19 2024-01-19
PrS Proposed sale
15,200
3.47
US$52,753 		15,200 3.47 US$52,753
2024-01-19 2024-01-19
PlS Planned sale
15,200 -2.9%
3.47
US$52,753 		15,200 -2.9% 3.47 US$52,753